Spots Global Cancer Trial Database for Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinoma
Official Title: An Open Label Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of ABX-EGF in Patients With Metastatic Colorectal Carcinoma
Study ID: NCT00111774
Interventions
Study Description
Brief Summary: The purpose of this study is to determine if ABX-EGF is safe and efficacious in patients with metastatic colorectal cancer.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Name: MD
Affiliation: Amgen
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
